R&D Bridging science and care: Advancing biomedical innovation As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help.
News Grail plans FDA filing for cancer blood test after new trial Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.
News AZ partners with Aptar on kidney disease-detecting AI AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD).
News Partner of ex-Theranos CEO raising cash for testing start-up The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup.
News Roche gets EU okay for chest pain algorithm Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.
Digital How data science and AI will transform life sciences in 2025 Even for an industry that depends on relentless innovation to thrive, life sciences have seen remarkable advancements in recent decades.
News AZ boasts phase 3 win for self-administered gMG drug Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face